Albinterferon alfa-2b
As of the edition of 20 October 2026, Albinterferon alfa-2b is a drug: in active development; acts on IFNAR1 and IFNAR2.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Active, 2016
- Kind
- Unknown
- Registered trials
- 10, 1 stopped early
- Disease areas
- Digestive system; Infections; Immune system; Cancer; Lungs and airways; Blood and lymph
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 7 | 6 | 0 | 1 |
| All trials | 10 |